Bronchial asthma
The drug DuoResp Spiromax is not intended for the initial treatment of bronchial asthma of intermittent and easy persistent flow.Selection of the dose of the preparations that make up the preparation DuoResp Spiromax takes place individually and depending on the severity of the disease. It's necessary to take into account not only at the beginning of treatment with combined preparations, but also with the change in the maintenance dose of the drug.
In the event that individual patients require different doses of a combination of active components than in Preparation DuoResp Spiromaks should assign β2-adrenoceptor agonists and / or corticosteroids in separate inhalers.
Patients should visit the doctor regularly to monitor the optimal dose of DuoResp Spiromax. The dose should be reduced to the lowest, against which the optimal control of symptoms of bronchial asthma remains. After achieving optimal control of asthma while taking the drug twice a day is recommended to titrate the dose to the minimum effective until the drug once a day, in cases where, in the judgment of the physician, the patient requires supportive therapy in combination with a bronchodilator long-acting .
Adults (18 years and over):
The drug DuoResp Spiromax 160 / 4.5 mcg / dose as maintenance therapy 1-2 inhalations twice a day. If necessary, it is possible to increase the dose to 4 inhalations twice a day.The patient should always have a separate inhaler with β2-adrenostimulyagorom short action for relief of attacks. Increased frequency of use of β2-adrenostimulants short-acting is an indicator of the deterioration of general control over the disease and requires revision of anti-asthma therapy.
The drug DuoResp Spiromax 160 / 4.5 mcg / dose as maintenance therapy and for relief of attacks
The drug DuoResp Spiromax can be prescribed as a permanent maintenance therapy, hack and as a therapy on demand in the event of seizures. As maintenance therapy and for relief of seizures, it is especially indicated for patients with:
- insufficient control of bronchial asthma and the need for frequent use of drugs to stop seizures;
- the presence in an anamnesis of exacerbations of bronchial asthma, requiring medical intervention.
It requires careful monitoring of dose-dependent side effects in patients who use a large number of inhalations to stop seizures. The recommended dose for maintenance therapy is 2 inhalations per day, 1 inhalation is taken in the morning and in the evening, or 2 inhalations once in the morning or only in the evening.For some patients, a maintenance dose may be prescribed drug DuoResp Spiromax 160 / 4.5 mcg / dose 2 inhalations twice a day. If symptoms occur, the appointment of 1 additional inhalation is necessary. With a further increase in symptoms within a few minutes, another 1 additional inhalation is prescribed, but no more than 6 inhalations for stopping 1 attack. Usually, no more than 8 inhalations per day are required, but you can increase the number of inhalations to 12 per day for a short time. Patients who receive more than 8 inhalations per day are advised to seek medical help for a review of therapy.
The drug DuoResp Spiromax 320/9 mcg / dose
1 inhalation twice a day. If necessary, it is possible to increase the dose to 2 inhalations twice a day.
After achieving the optimal control of the symptoms of bronchial asthma on the background of taking the drug twice a day, it is possible to reduce the dose to the lowest effective, up to a dose once a day.
COPD
Adults (18 years and over):
DuoResp Spiromax 160 / 4.5 mcg / dose 2 inhalations of the drug twice daily.
DuoResp Spiromax 320/9 mcg / dose 1 inhalation of the drug twice daily.
Special patient groups
There is no need for a special dose selection for elderly patients. There are no data on the use of DuoResp Spiromax in patients with renal or hepatic insufficiency. How budesonide and formoterol are excreted mainly by the kidneys, with the participation of hepatic metabolism, then in patients with severe cirrhosis of the liver, a slowing down of the drug release rate can be expected.
Mode of application
DuoResp Spiromax is a drug activated by inhalation, which means the entry of the active substance into the respiratory tract, when the patient inhales it from the mouthpiece. Patients with moderate to severe asthma are able to develop a sufficient flow rate on inhalation to receive a therapeutic dose of DuoResp Spiromax.
To ensure effective treatment, DuoResp Spiromax should be used correctly. Therefore, patients should be advised to carefully read the instructions for use and follow the instructions for medical use.
The use of DuoResp Spiromax consists of three steps.
1. Open the lid of the mouthpiece by turning it down until it is heard click and it will not open.
2. Place the mouthpiece between the teeth, closing the lips around it, without biting the mouthpiece of the inhaler. Deeply inhale from the dispenser. Get the mouthpiece from the mouth and hold your breath for 10 seconds or longer - as much as it is comfortable for the patient.
3. Carefully exhale the air and close the dispenser cover.
It is important not to shake the inhaler before use, do not exhale into the mouthpiece and do not hold your breath, preparing for inhalation.
After inhalation, rinse the oral cavity with water.
When using the drug DuoResp Spiromax, the patient can feel a specific taste due to the presence of an auxiliary substance - lactose.